# Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Healthy Male Volunteers

> **NCT01134549** · PHASE1 · COMPLETED · sponsor: **KAI Pharmaceuticals** · enrollment: 32 (actual)

## Conditions studied

- Hyperparathyroidism, Secondary

## Interventions

- **DRUG:** Etelcalcetide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01134549
- **Lead sponsor:** KAI Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06-09
- **Primary completion:** 2010-07-31
- **Final completion:** 2010-07-31
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2017-04-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01134549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01134549, "Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Healthy Male Volunteers". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01134549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*